23 diciembre 2014
A new test may reveal which patients will respond to treatment for graft versus host disease (GVHD), an often life-threatening complication of stem cell transplants (SCT) used to treat leukemia and other blood disorders, according to a study.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Fd9azG11PNA/141223084002.htm
